학술논문
The need for a commercial test using the penA60 allele to identify ceftriaxone-resistant Neisseria gonorrhoeae
Document Type
Discussion
Source
In The Lancet Infectious Diseases September 2022 22(9):1271-1272
Subject
Language
ISSN
1473-3099